查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1622100

全球重要器官支持系统和医疗仿生市场规模（按产品、最终用户、地区、范围和预测）

Global Vital Organs Support Systems And Medical Bionics Market Size By Product (Vital Organs Support Systems, Medical Bionics), By End-User (Hospitals, Ambulatory Surgical Centers), By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

重要器官支持系统和医疗仿生学的市场规模和预测

重要器官支持系统和医疗仿生市场规模在 2024 年价值 464.3 亿美元，预计从 2024 年到 2031 年将以 9.60% 的复合年增长率增长，到 2031 年将达到 966.6 亿美元。其背景是器官捐赠者短缺，器官移植例数上升，因遗传疾病或意外事故需要器官移植的人数增加，慢性病发生率上升。本研究报告对全球重要器官支持系统和医疗仿生市场进行了全面的评估和分析。它对关键细分市场、趋势、市场推动因素、阻碍因素、竞争格局以及在市场中发挥关键作用的因素进行了全面的分析。

全球重要器官支持系统与医疗仿生市场的定义

组成器官支持系统的人工器官是为了模仿自然的人体器官功能而创建的，用于替换缺失或受损的器官或支持已经发挥功能的器官。这些人造器官与活体组织相连，取代缺失的人体器官。

复製生物体或特定生物部位的机械系统的研究称为医学仿生学。重要器官支持系统和医疗仿生技术具有减少对人类捐赠者的依赖、减轻器官排斥风险以及为多种疾病提供更便宜的治疗选择的优势。这些优势有望帮助扩大医疗仿生学和重要器官支持系统的市场。

全球器官辅助系统与医疗仿生市场概况

近年来，全球重要器官支持系统和医疗仿生市场经历了显着扩张，预计市场占有率和价值都将继续大幅增长。其背景是器官捐赠者短缺，器官移植病例上升，由于遗传或意外残疾等需要器官移植的人数增加，慢性病发生率上升。此外，老年人口持续成长和产品技术进步等因素预计将在整个预测期内推动全球医疗仿生和重要器官支持系统市场的成长。

然而，预计医疗仿生学和器官支持系统市场的成长将受到义肢和医疗仿生学的高成本以及严格的监管审批程序的限制。此外，优惠的报销政策、公共和私营部门的财政支持以及有利的医疗保险计划可能会在未来几年支持医疗仿生和重要器官支持系统市场的成长。

目录

第 1 章 重要器官支持系统与医疗仿生学的全球市场：简介

  • 市场定义
  • 市场区隔
  • 调查安排
  • 先决条件
  • 限制

第 2 章：经过验证的市场研究方法

  • 资料探勘
  • 数据三角测量
  • 由下而上的方法
  • 自上而下的方法
  • 调查流程
  • 产业专家的重要见解
  • 资料来源

第 3 章执行摘要

    市场概况
  • 生态製图
  • 绝对的获利机会
  • 市场吸引力
  • 重要器官支持系统与医疗仿生学的全球市场：区域分析
  • 全球重要器官支持系统与医疗仿生学市场（依产品划分）
  • 全球重要器官支持系统和医疗仿生学市场（按最终用户划分）
  • 未来市场机会
  • 全球市场划分
  • 产品生命线

第 4 章 重要器官支持系统与医疗仿生学的全球市场展望

  • 全球重要器官支持系统与医疗仿生学的发展
  • 驱动程式
  • 阻碍因素
  • 机会
  • 波特五力模型
  • 价值链分析
  • 价格分析
  • 宏观经济分析

第5章全球重要器官支持系统与医疗仿生学市场（依产品划分）

  • 概述
  • 重要器官支持系统
    • 人工心臟
    • 人工肾
    • 人工肝臟
    • 其他
  • 医学仿生学
    • 心臟仿生学
    • 骨科仿生学
    • 神经仿生学
    • 其他

第6章 主要器官支持系统和医疗仿生学的全球市场（按最终用户划分）

  • 概述
  • 医院
  • 门诊手术中心
  • 其他

第7章全球重要器官支持系统与医疗仿生学市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他欧洲国家
    亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲国家
  • 中东和非洲
    • 阿拉伯联合大公国
    • 沙乌地阿拉伯
    • 南非
    • 其他中东和非洲地区

第8章 重要器官支持系统与医疗仿生学的全球市场：竞争格局

  • 概述
  • 各公司的市场排名
  • 重大进展
  • 公司地理分布
  • 公司产业足迹
  • ACE 矩阵

第9章 公司简介

  • Abiomed Inc
  • Abbott Laboratories（St. Jude Medical）
  • Asahi Kasei Corporation（Evaheart Medical U.S.A. Inc）
  • Baxter International Inc
  • Boston Scientific Corporation
  • Cochlear Ltd
  • Edwards Lifesciences Corporation
  • Jarvik Heart Inc
  • Medtronic Plc（Covidien Ltd）
  • Ossur Americas Inc
  • Second Sight Medical Products Inc
  • SynCardia Systems LLC

第 10 章 经过验证的市场情报

    关于经过验证的市场情报
  • 动态资料视觉化
简介目录
Product Code: 15317

Vital Organs Support Systems And Medical Bionics Market Size And Forecast

Vital Organs Support Systems And Medical Bionics Market size was valued at USD 46.43 Billion in 2024 and is projected to reach USD 96.66 Billion By 2031, growing at a CAGR of 9.60% from 2024 to 2031. This is brought on by a dearth of organ donors, an increase in organ transplant cases, a rise in the number of persons needing organ transplants due to hereditary or accidental disabilities, and a rise in the incidence of chronic diseases. The Global Vital Organs Support Systems And Medical Bionics Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Vital Organs Support Systems And Medical Bionics Market Definition

The artificial organs that make up the Organ Support System are created to mimic natural human organ function and are used to replace missing or damaged organs as well as support already functioning organs. These synthetic organs connect to living tissues and take the place of missing human organs.

The study of mechanical systems that duplicate organisms or specific living organism parts is known as medical bionics. Artificial organ support systems and medical bionics have the advantages of lessening the dependence on human donors, reducing the risk of organ rejection, and providing a more affordable treatment option for a variety of disorders. These advantages are anticipated to assist the market for medical bionics and systems to support essential organs as they expand.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Vital Organs Support Systems And Medical Bionics Market Overview

In recent years, the global market for medical bionics and systems to support important organs has experienced significant expansion, and in the years to come, it is anticipated to continue to expand significantly both in terms of share and value. This is brought on by a dearth of organ donors, an increase in organ transplant cases, a rise in the number of persons needing organ transplants due to hereditary or accidental disabilities, and a rise in the incidence of chronic diseases. Additionally, throughout the forecast period, factors such as the continually growing elderly population, and advancements in product technologies are anticipated to boost the growth of the global market for medical bionics and vital organ support systems.

However, the market growth for medical bionics and vital organ support systems is anticipated to be constrained by the high cost of artificial devices and medical bionics as well as strict regulatory approval procedures. Moreover, in the coming years, favorable reimbursement policies, financial support from the public and private sectors, as well as favorable healthcare coverage schemes, will support the growth of the market for medical bionics and systems that support vital organs.

Global Vital Organs Support Systems And Medical Bionics Market Segmentation Analysis

The Global Vital Organs Support Systems And Medical Bionics Market is Segmented based on Product, End-User, And Geography.

Vital Organs Support Systems And Medical Bionics Market, By Product

  • Vital Organs Support Systems
  • Artificial Heart
  • Artificial Kidney
  • Artificial Liver
  • Others
  • Medical Bionics
  • Cardiac Bionics
  • Orthopedic Bionics
  • Neural Bionics
  • Others

Based on product, the market is segmented into vital organs support systems, and medical bionics. The vital organs support systems segment is segmented into artificial hearts, artificial livers, artificial kidneys, and others. The medical bionics market is classified into cardiac bionics, orthopedic bionics, neural bionics, and others. The vital organs support systems segment dominated the major market share of the vital organs support systems and medical bionics market. The growth of the segment is primarily attributed to a surge in patient acceptance that is poised to increase as more people become aware of medical bionics. Continuous advances in the fields of biomedical engineering and medical science are anticipated to increase the use rate of synthetic organs during the projected period.

Vital Organs Support Systems And Medical Bionics Market, By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Based on End-User, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Others. the hospital segment dominated the major market share of the vital organs support systems and medical bionics market. The availability of numerous support departments, including MRI suites and ICUs, is responsible for the segment's expansion. Additionally, hospitals have more staff on hand to deal with complications. When complications arise during an operation, patients are frequently transferred from an ambulatory surgery center to the closest hospital, which will speed up the growth of the hospital segment throughout the forecast period.

Vital Organs Support Systems And Medical Bionics Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin Ameria
  • Middle East & Africa

Based on Geography, the Global Vital Organs Support Systems And Medical Bionics Market is classified into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market for medical bionics and systems to support key organs is dominated mostly by North America. This can be attributed to the rising prevalence of artificial organs in emerging markets, the existence of numerous key players participating in this market, the presence of a large number of players working in this industry, as well as the potential growth of healthcare spending. Furthermore, because cadaveric organ donation is so uncommon, artificial organ transplants are probably going to become more typical. An increasing number of new product approvals linked to the best use of innovative transplants are predicted to fuel market expansion over the forecast period. The industry is positioned to be driven by significant private-sector expenditures.

  • However, due to the rising prevalence of amputations from trauma and accidents, as well as brain injuries that cause visual and hearing loss, Asia-Pacific is predicted to have the fastest growth during the forecast period. Additionally, it is anticipated that demand for medical bionics and critical organ support systems will increase as a result of improved patient awareness and increased investment by major market players in developing economies, which is expected to fuel market growth throughout the forecast period for the market for these products.

Key Players

  • The "Global Vital Organs Support Systems And Medical Bionics Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as
  • Abiomed Inc., Abbott Laboratories (St. Jude Medical), Baxter International Inc., Second Sight Medical Products Inc, Boston Scientific Corporation, Cochlear Ltd, Edwards Lifesciences Corporation, Jarvik Heart Inc, Asahi Kasei Corporation (Evaheart Medical U.S.A. Inc), Medtronic Plc (Covidien Ltd), Ossur Americas Inc, SynCardia Systems LLC, and others.
  • Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.'

Key Developments

  • In 2020, Sonova Group unveiled its EXCITE-Pro platform, which was demonstrated by HANSATON, a manufacturer and provider of hearing systems.
  • Kindred Healthcare, LLC and Ekso Bionics Holdings, Inc. collaborated to pilot EksoNR, a robotic exoskeleton, in their long-term acute care hospitals in 2020.
  • In 2020, the Cobalt & Crome portfolio of Cardiac Resynchronization Therapy-Defibrillators (CRT-D) and Implantable Cardioverter-Defibrillators (ICD) from Medtronic Plc. received the Conformite Europeenne (CE) mark.
  • Ace Matrix Analysis
  • The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories
  • Active, Cutting Edge, Emerging, and Innovators.
  • Market Attractiveness
  • The image of market attractiveness provided would further help to get information about the region that is majorly leading in the global Vital Organs Support Systems And Medical Bionics market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.
  • Porter's Five Forces
  • The image provided would further help to get information about Porter's five forces framework providing a blueprint for understanding the behavior of competitors and a player's strategic positioning in the respective industry. Porter's five forces model can be used to assess the competitive landscape in the global Vital Organs Support Systems And Medical Bionics market, gauge the attractiveness of a certain sector, and assess investment possibilities.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET

  • 1.1 Market Definition
  • 1.2 Market Segmentation
  • 1.3 Research Timelines
  • 1.4 Assumptions
  • 1.5 Limitations

2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 2.1 Data Mining
  • 2.2 Data Triangulation
  • 2.3 Bottom-Up Approach
  • 2.4 Top-Down Approach
  • 2.5 Research Flow
  • 2.6 Key Insights from Industry Experts
  • 2.7 Data Sources

3 EXECUTIVE SUMMARY

  • 3.1 Market Overview
  • 3.2 Ecology Mapping
  • 3.3 Absolute Market Opportunity
  • 3.4 Market Attractiveness
  • 3.5 Global Vital Organs Support Systems And Medical Bionics Market Geographical Analysis (CAGR %)
  • 3.6 Global Vital Organs Support Systems And Medical Bionics Market, By Product (USD Million)
  • 3.7 Global Vital Organs Support Systems And Medical Bionics Market, By End-User (USD Million)
  • 3.8 Future Market Opportunities
  • 3.9 Global Market Split
  • 3.10 Product Life Line

4 GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET OUTLOOK

  • 4.1 Global Vital Organs Support Systems And Medical Bionics Evolution
  • 4.2 Drivers
    • 4.2.1 Driver 1
    • 4.2.2 Driver 2
  • 4.3 Restraints
    • 4.3.1 Restraint 1
    • 4.3.2 Restraint 2
  • 4.4 Opportunities
    • 4.4.1 Opportunity 1
    • 4.4.2 Opportunity 2
  • 4.5 Porters Five Force Model
  • 4.6 Value Chain Analysis
  • 4.7 Pricing Analysis
  • 4.8 Macroeconomic Analysis

5 GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT

  • 5.1 Overview
  • 5.2 Vital Organs Support Systems
    • 5.2.1 Artificial Heart
    • 5.2.2 Artificial Kidney
    • 5.2.3 Artificial Liver
    • 5.2.4 Others
  • 5.3 Medical Bionics
    • 5.3.1 Cardiac Bionics
    • 5.3.2 Orthopedic Bionics
    • 5.3.3 Neural Bionics
    • 5.3.4 Others

6 GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END-USER

  • 6.1 Overview
  • 6.2 Hospitals
  • 6.3 Ambulatory Surgical Centers
  • 6.4 Others

7 GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Argentina
    • 7.5.3 Rest of Latin America
  • 7.6 Middle-East and Africa
    • 7.6.1 UAE
    • 7.6.2 Saudi Arabia
    • 7.6.3 South Africa
    • 7.6.4 Rest of Middle-East and Africa

8 GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Developments
  • 8.4 Company Regional Footprint
  • 8.5 Company Industry Footprint
  • 8.6 ACE Matrix

9 COMPANY PROFILES

  • 9.1 Abiomed Inc
    • 9.1.1 Company Overview
    • 9.1.2 Company Insights
    • 9.1.3 Product Benchmarking
    • 9.1.4 Key Development
    • 9.1.5 Winning Imperatives
    • 9.1.6 Current Focus & Strategies
    • 9.1.7 Threat from Competition
    • 9.1.8 SWOT Analysis
  • 9.2 Abbott Laboratories (St. Jude Medical)
    • 9.2.1 Company Overview
    • 9.2.2 Company Insights
    • 9.2.3 Product Benchmarking
    • 9.2.4 Key Development
    • 9.2.5 Winning Imperatives
    • 9.2.6 Current Focus & Strategies
    • 9.2.7 Threat from Competition
    • 9.2.8 SWOT Analysis
  • 9.3 Asahi Kasei Corporation (Evaheart Medical U.S.A. Inc)
    • 9.3.1 Company Overview
    • 9.3.2 Company Insights
    • 9.3.3 Product Benchmarking
    • 9.3.4 Key Development
    • 9.3.5 Winning Imperatives
    • 9.3.6 Current Focus & Strategies
    • 9.3.7 Threat from Competition
    • 9.3.8 SWOT Analysis
  • 9.4 Baxter International Inc
    • 9.4.1 Company Overview
    • 9.4.2 Company Insights
    • 9.4.3 Product Benchmarking
    • 9.4.4 Key Development
    • 9.4.5 Winning Imperatives
    • 9.4.6 Current Focus & Strategies
    • 9.4.7 Threat from Competition
    • 9.4.8 SWOT Analysis
  • 9.5 Boston Scientific Corporation
    • 9.5.1 Company Overview
    • 9.5.2 Company Insights
    • 9.5.3 Product Benchmarking
    • 9.5.4 Key Development
    • 9.5.5 Winning Imperatives
    • 9.5.6 Current Focus & Strategies
    • 9.5.7 Threat from Competition
    • 9.5.8 SWOT Analysis
  • 9.6 Cochlear Ltd
    • 9.6.1 Company Overview
    • 9.6.2 Company Insights
    • 9.6.3 Product Benchmarking
    • 9.6.4 Key Development
    • 9.6.5 Winning Imperatives
    • 9.6.6 Current Focus & Strategies
    • 9.6.7 Threat from Competition
    • 9.6.8 SWOT Analysis
  • 9.7 Edwards Lifesciences Corporation
    • 9.7.1 Company Overview
    • 9.7.2 Company Insights
    • 9.7.3 Product Benchmarking
    • 9.7.4 Key Development
    • 9.7.5 Winning Imperatives
    • 9.7.6 Current Focus & Strategies
    • 9.7.7 Threat from Competition
    • 9.7.8 SWOT Analysis
  • 9.8 Jarvik Heart Inc
    • 9.8.1 Company Overview
    • 9.8.2 Company Insights
    • 9.8.3 Product Benchmarking
    • 9.8.4 Key Development
    • 9.8.5 Winning Imperatives
    • 9.8.6 Current Focus & Strategies
    • 9.8.7 Threat from Competition
    • 9.8.8 SWOT Analysis
  • 9.9 Medtronic Plc (Covidien Ltd)
    • 9.9.1 Company Overview
    • 9.9.2 Company Insights
    • 9.9.3 Product Benchmarking
    • 9.9.4 Key Development
    • 9.9.5 Winning Imperatives
    • 9.9.6 Current Focus & Strategies
    • 9.9.7 Threat from Competition
    • 9.9.8 SWOT Analysis
  • 9.10 Ossur Americas Inc
    • 9.10.1 Company Overview
    • 9.10.2 Company Insights
    • 9.10.3 Product Benchmarking
    • 9.10.4 Key Development
    • 9.10.5 Winning Imperatives
    • 9.10.6 Current Focus & Strategies
    • 9.10.7 Threat from Competition
    • 9.10.8 SWOT Analysis
  • 9.11 Second Sight Medical Products Inc
    • 9.11.1 Company Overview
    • 9.11.2 Company Insights
    • 9.11.3 Product Benchmarking
    • 9.11.4 Key Development
    • 9.11.5 Winning Imperatives
    • 9.11.6 Current Focus & Strategies
    • 9.11.7 Threat from Competition
    • 9.11.8 SWOT Analysis
  • 9.12 SynCardia Systems LLC
    • 9.12.1 Company Overview
    • 9.12.2 Company Insights
    • 9.12.3 Product Benchmarking
    • 9.12.4 Key Development
    • 9.12.5 Winning Imperatives
    • 9.12.6 Current Focus & Strategies
    • 9.12.7 Threat from Competition
    • 9.12.8 SWOT Analysis

10 VERIFIED MARKET INTELLIGENCE

  • 10.1 About Verified Market Intelligence
  • 10.2 Dynamic Data Visualization